Collectively, these data suggest the predominant role of Gαq/Calcium/PPAR-γ/Arg1 signaling as well as L-Arginine consumption in FFAR2 mediated immune suppression, which have great potential to be targets for cancer immunotherapy. The gene discussed is PPARG; the disease is cancer.